Navigation Links
PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
Date:8/15/2011

LAKE FOREST, Ill., Aug. 15, 2011 /PRNewswire/ -- PharMEDium Services, LLC, market leader for customized pharmacy sterile compounding for hospital intravenous and epidural therapies, launched its new website, www.pharmedium.com, which now provides updates on drug shortages, patient safety and ready-to-use pharmacy compounding services.  Hospital customers can easily obtain valuable information on PharMEDium's broad range of services designed to reduce waste, improve efficiency and enhance patient safety. The PharMEDium website design provides information necessary to facilitate a hospital's selection of the right partner for compounded sterile preparations and demonstrates the qualities to look for when assessing a possible outsourced pharmacy sterile compounding service provider.  The result of choosing a partner that ranks high in regulatory compliance, quality and patient safety measures, medication administration safety features and service excellence is the selection of a reputable and reliable outsourced pharmacy sterile compounding service provider.  

Amy Langan, VP of Marketing and Business Development, commented, "PharMEDium's new website demonstrates our ongoing commitment to improve on our customer service experience providing innovative customized pharmacy sterile compounding solutions to the market we serve.  We conducted extensive customer research to ensure that our website design and development met the mark for enhancing patient safety.  We succeeded by making valuable service information easier to locate, use and refer to at the touch of a key."

PharMEDium hospital customers want easy access to drug shortage information and ready-to-use pharmacy compounding service updates as well as convenient online ordering capability for DEA Schedule II Controlled Substances.  Central to PharMEDium Services is www.pharmedium.com, where convenient online ordering for customers resides.  Online ordering has been propelled to the next generation by the establishment of the Controlled Substance Online System "CSOS" for ordering DEA Schedule II Controlled Substances.

David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation stated, "PharMEDium's launch of an enhanced website experience is yet another example of our commitment to provide hospital customers with continuous service improvements.  Our wide-range of pharmacy compounding services, innovative processes and customer service demonstrates our continued commitment to be the national leader in hospital outsourced compounding services."

PharMEDium is the national leading provider of customized pharmacy sterile compounding for hospital intravenous and epidural therapies. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.


'/>"/>
SOURCE PharMEDium Services, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
2. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
3. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
4. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
5. PharMEDium Elects William R. Spalding to Board of Directors
6. Echo Therapeutics Unveils Symphony tCGM Demonstration Video
7. Clearbridge BioLoc Unveils Innovative Lab-on-Card Analysis Platform for Point-of-Care Testing at Worlds Largest Clinical Lab Conference
8. Siemens Unveils Innovation Power for the Clinical Laboratory at 2011 AACC and ASCLS Annual Meetings and Clinical Lab Expo
9. IncellDx CEO Unveils Revolutionary New Tool In The Fight Against Cancer
10. Wellsense Unveils First-Ever Bedside Patient Pressure Mapping System Designed to Assist Caregivers in Effectively Repositioning Patients
11. Omnicell Unveils Largest Ever Medication and Supply Automation Product Launch: the G4 Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... 19, 2017 Companion ... response in pets such as canine, avian and ... various types such as Attenuated Live Vaccines, Conjugate ... Vaccines and Recombinant Vaccines. Attenuated live vaccines are ... bacteria, which have been weakend under laboratory conditions. ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... expanded distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark ... patients with diabetes. The GlycoMark test provides a clinically proven one- to two-week ...
(Date:4/28/2017)... ... 2017 , ... Children and adolescents who enter the foster ... in the general population. That’s because foster care is designed to protect children ... no fault of their own, youth who have experienced trauma often have difficulty ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain company ... Tina Howe joined the team, the Bill Howe brand was born and they began ... and giving back to the San Diego community in which they worked, lived and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... respiratory hospital, based in Denver, Colorado, announced an agreement to create the Jane ... continuing support of the Jane and Leonard Korman Family Foundation. The collaboration leverages ...
Breaking Medicine News(10 mins):